Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-026388

Chief Medical Officer acquired 6,418 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Luke Thomas Charles Chief Medical Officer 2021-10-19 Grant or award +990 $10.10 $9,999 990 D: show line 1 in the form
Luke Thomas Charles Chief Medical Officer 2021-10-22 Grant or award +5,428 5,428 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Luke Thomas Charles Chief Medical Officer 2021-10-22 Grant or award · Earnout Rights (Common Stock) +2,193 2,193 D: show line 3 in the form
Luke Thomas Charles Chief Medical Officer 2021-10-22 Grant or award · Employee Stock Option (right to buy) +139,585 139,585 D: show line 4 in the form
Luke Thomas Charles Chief Medical Officer 2021-10-22 Grant or award · Employee Stock Option (right to buy) +11,632 11,632 D: show line 5 in the form
Luke Thomas Charles Chief Medical Officer 2021-10-22 Grant or award · Earnout Rights (Restricted Stock Units) +61,092 61,092 D: show line 6 in the form
Loading xslF345X03/ownership.xml…